Oral versus intravenous palonosetron in Chinese cancer...

  • Main
  • 2020 / 06
  • Oral versus intravenous palonosetron in Chinese cancer...

Oral versus intravenous palonosetron in Chinese cancer patients receiving moderately emetogenic chemotherapy: A non‐inferiority phase III trial

Cui, Jiuwei, Zhang, Qingyuan, Zhang, Hongyu, Spinelli, Tulla, Nicolas, Pierre, Li, Wei
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
European Journal of Cancer Care
DOI:
10.1111/ecc.13245
Date:
June, 2020
File:
PDF, 554 KB
2020
Conversion to is in progress
Conversion to is failed